Associations of food groups and cardiometabolic and inflammatory biomarkers: does the meal matter?


Journal

The British journal of nutrition
ISSN: 1475-2662
Titre abrégé: Br J Nutr
Pays: England
ID NLM: 0372547

Informations de publication

Date de publication:
28 09 2019
Historique:
pubmed: 25 6 2019
medline: 9 6 2020
entrez: 25 6 2019
Statut: ppublish

Résumé

Increased attention has been paid to circadian patterns and how predisposition to metabolic disorders can be affected by meal timing. Currently, it is not clear which role can be attributed to the foods selected at meals. On a cross-sectional sub-cohort study (815 adults) within the European Prospective Investigation into Cancer and Nutrition-Potsdam study, we investigated whether the same foods (vegetables, fruits, refined grains, whole grains, red and processed meats) eaten at different meals (breakfast, lunch or dinner) show different associations with biomarkers of cardiometabolic risk. Meal-specific usual intakes were calculated from multiple 24-h dietary recalls. Multivariable-adjusted linear regression models showed that intake of vegetables at breakfast was associated with lower LDL-cholesterol (-0·37 mmol/l per 50 g; 95 % CI -0·61, -0·12) and vegetables at dinner was associated with higher HDL-cholesterol (0·05 mmol/l per 50 g; 95 % CI 0, 0·10). Fruit intake at breakfast was associated with lower glycated Hb (HbA1c) (-0·06 % per 50 g; 95 % CI -0·10, -0·01) and fruits at dinner with lower C-reactive protein (CRP) (-0·21 mg/l per 50 g; 95 % CI -0·42, -0·01). Red and processed meat intake at breakfast was associated with higher HbA1c (0·25 % per 50 g; 95 % CI 0·05, 0·46) and CRP (0·76 mg/l per 50 g; 95 % CI 0·15, 1·36). Our results suggest that by preferring fruits and vegetables and avoiding red and processed meats at specific meals (i.e. breakfast and dinner), cardiometabolic profiles and ultimately chronic disease risk could be improved. Lunch seemed to be a less important meal in terms of food-biomarker associations.

Identifiants

pubmed: 31230610
pii: S000711451900151X
doi: 10.1017/S000711451900151X
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

707-716

Auteurs

Carolina Schwedhelm (C)

Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), Nuthetal, Germany.
NutriAct - Competence Cluster Nutrition Research Berlin-Potsdam, Nuthetal, Germany.

Lukas Schwingshackl (L)

Institute for Evidence in Medicine, Faculty of Medicine and Medical Center - University of Freiburg, Freiburg, Germany.

George O Agogo (GO)

Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.

Emily Sonestedt (E)

Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.

Heiner Boeing (H)

Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), Nuthetal, Germany.
NutriAct - Competence Cluster Nutrition Research Berlin-Potsdam, Nuthetal, Germany.

Sven Knüppel (S)

Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), Nuthetal, Germany.
Department of Nutrition and Gerontology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), Nuthetal, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH